-
Additional $1 Billion May Seal J&J Talc Settlement with Ovarian Cancer Victims
After years of negotiations, an additional $1.1 billion in compensation may be what seals a settlement deal for ovarian cancer victims seeking justice from Johnson & Johnson. If accepted, the agreement would resolve the litigation issues specific to those suffering gynecologic effects from using the company’s baby powder and other talc powder products but does
-
Man’s Mesothelioma Blamed on Asbestos in Talc Used for Pleurodesis
Talc pleurodesis is a medical procedure that is used to prevent the build-up of fluid or air in the pleural lining. It provides relief to patients suffering from several lung conditions, including malignant pleural mesothelioma, but in the case of Salt Lake City, Utah resident Bryce Zundel, the talc used in the procedures he underwent
-
Mesothelioma Victim Wins New Trial Against Stucco Company
The California Court of Appeals has granted mesothelioma victim Kevin Brooks and his wife a new trial after a jury found that Mission Stucco’s products were a substantial factor in Mr. Brooks’ illness but also found that the company had no comparative fault. The appeals court granted a new trial to redetermine the apportionment of fault:
-
Washington State Asbestos Company Fined Over Mismanagement, Risk of Mesothelioma
Before it became known that asbestos causes mesothelioma and other deadly illnesses, it was used in thousands of applications and products, particularly in construction materials. Though that use has stopped, legacy asbestos continues to pose a threat in homes, schools, and other buildings. Asbestos abatement companies remove the toxic material in compliance with local, state, and
-
Mesothelioma Victims Argue Against Bestwall Bankruptcy
Bestwall LLC is a subsidiary of Georgia-Pacific that was formed as part of a bankruptcy filing by Georgia-Pacific, a company that faces significant mesothelioma and asbestos liabilities. It was one of the first uses of a controversial bankruptcy strategy called a Texas Two Step that allows companies that are fiscally sound to assign their liabilities
-
Mesothelioma Victims’ Estates Say Companies “Strategically Delayed” Compensation
The families of two Montana mesothelioma victims who won millions in compensation from BNSF Railway Company have now filed a complaint in a federal court, saying that the company and its insurer breached their claim-handling duties and strategically delayed the resolution of their claims to earn interest income on the money that was owed to
-
Leader at Renowned Cancer Center Expresses Hope for Mesothelioma Treatment
The Peter MacCallum Cancer Center is a renowned cancer treatment center that has been a leader in mesothelioma research. Located in Melbourne, Australia, the facility affectionately referred to as “Peter Mac” is credited with several breakthroughs in cancer treatment, including having discovered the “Hippo” signaling pathway that holds promise for a better understanding of the
-
Mesothelioma Tragedy Continues in the United Kingdom
Malignant mesothelioma is a rare and fatal form of cancer striking approximately 3,500 Americans every year. Its impact is far greater in the United Kingdom. The European nation has a much smaller population than the U.S. but sees 2,700 mesothelioma deaths and 5,000 asbestos-related disease deaths each year, representing a much larger ratio of incidence. Though
-
Despite Affidavits, Judge Denies DAP’s Request for Dismissal from Mesothelioma Case
Earlier this year, Navy veteran Paul J. McPolin succumbed to an asbestos-related illness that his family blames on exposure to dozens of products contaminated with the carcinogenic mineral. One of the defendants named in the family’s personal injury lawsuit, DAP, Inc., filed a motion for summary judgment arguing that they did not manufacture or sell
-
New York Judge Denies DAP’s Motion to Dismiss Veteran’s Lung Cancer Claim
Navy veteran John P. Reeves was diagnosed with asbestos-related lung cancer after a lifetime of exposure to asbestos-containing products. He filed a personal injury lawsuit naming several companies whose products contained asbestos as defendants, including DAP, Inc., a manufacturer of caulking products. The company filed a motion to dismiss the case, arguing that not all
-
Former Con Ed Employee’s Lung Cancer Blamed on Asbestos-Contaminated Equipment
Malignant mesothelioma and other forms of lung cancer have both been linked directly to asbestos. Exposure to the carcinogenic mineral has sickened and killed hundreds of thousands of people globally. In the United States, victims of negligent exposure to asbestos can seek compensation from those responsible. Earlier this month, a New York court told Robert
-
Talc Supplier’s “Just Following Orders” Argument Fails in Mesothelioma Claim
Facing a personal injury lawsuit from a woman diagnosed with malignant mesothelioma, talc manufacturer Kolmar Laboratories filed a motion for summary judgment, asking that the claim against them be dismissed. But Justice Adam Silvera of the Supreme Court of New York County denied the company’s petition, noting that it had failed to meet the bar
-
Mesothelioma Victim Awarded $63.4 Million by South Carolina Jury
In the latest legal blow against Johnson & Johnson and its talc-based products, a South Carolina state court jury ordered the company to pay $63.4 million in compensatory and punitive damages to a man diagnosed with malignant mesothelioma. Michael Perry was diagnosed with the rare, asbestos-related disease at the age of 53 and blamed his
-
Asbestos Lung Cancer Blamed on Electric Supplier’s Products
Paul Scandaliato was diagnosed with lung cancer after more than forty years of working for Con Edison in New York. He filed an asbestos lawsuit that named dozens of companies whose asbestos-contaminated products he was exposed to or worked with during his career. One of those companies, Kennedy Electrical Supply Corporation, asked to be dismissed
-
Avon Files for Bankruptcy in Face of Talc Mesothelioma Lawsuits
Following significant jury verdicts in favor of mesothelioma and ovarian cancer victims, iconic cosmetic company Avon has filed for Chapter 11 bankruptcy protection. The company’s court filings assert that it expects that there will be an increasing number of personal injury lawsuits filed against it and that it no longer has “sufficient liquidity to litigate
-
Asbestos Company’s Argument Rejected by Judge in Lung Cancer Case
Guiseppe Rullo was diagnosed with asbestos-related lung cancer after a decade of working at Con Ed. He and his wife have filed suit against multiple manufacturers of the asbestos-containing products to which he was exposed during that time. One of those companies, Atwood & Morrill Co., Inc., attempted to evade responsibility by pointing to a
-
South Carolina Jury to Decide Johnson & Johnson Mesothelioma Case
The cruel irony of malignant mesothelioma is that the asbestos that causes the disease is so often meant to protect. It happened when the military ordered asbestos to be used, leading to countless veterans’ illnesses, and more recently it’s what led to Michael Perry’s diagnosis with the fatal disease. Suffering from an allergy to most
-
West Virginia Hospital Named in Asbestos Lung Cancer Lawsuit
A young woman diagnosed with asbestos-related lung cancer has filed a personal injury lawsuit against West Virginia University Hospitals, Inc. and Metropolitan Life Insurance. Her claim asserts that she was exposed to legacy asbestos during her years as a nursing student and accuses the organizations of negligence and asbestos misrepresentation.
-
Biotech Company’s AI-Driven Treatment for Mesothelioma Receives FDA Clearance
A Hong-Kong-based biotech company that combines genomics, big data analysis, and deep learning for drug discovery has just received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance for the use of its newest innovation for the treatment of malignant mesothelioma. The company’s pan-TEAD inhibitor, ISM6331, was created with the help of Artificial
-
Researchers’ Breath Test Innovation May Be Gamechanger for Mesothelioma Diagnosis
In searching for better outcomes for patients with malignant pleural mesothelioma and asbestos-related lung cancer, achieving earlier diagnosis is a top priority that would facilitate faster and more effective treatment. Two papers published by researchers from a laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) may signal a real breakthrough in achieving
